Search

Your search keyword '"Kimby, Eva"' showing total 397 results

Search Constraints

Start Over You searched for: Author "Kimby, Eva" Remove constraint Author: "Kimby, Eva" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
397 results on '"Kimby, Eva"'

Search Results

1. Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma

2. Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma

4. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

7. Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials

8. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

10. Genetic and Microenvironment Features Do Not Distinguish Follicular Lymphoma Patients Requiring Immediate or Deferred Treatment

11. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

12. Survival by First-line Treatment Type and Timing of Progression Among Follicular Lymphoma Patients: A National Population-based Study in Sweden

13. Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia

15. Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma

18. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

19. Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

21. Diversity of Intratumoral Regulatory T Cells in Non-Hodgkin Lymphoma

24. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

26. Bortezomib in Combination with Dexamethasone, Rituximab and Cyclophosphamide (B-DRC) As First - Line Treatment of Waldenstrom's Macroglobulinemia: Results of a Prospectively Randomized Multicenter European Phase II Trial

27. Heterogeneity of Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma

29. ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

32. A Multistate Survival Analysis for Patients with Follicular Lymphoma (FL) Using 13 First-Line Randomized Trials from FL Analysis of Surrogate Hypothesis (FLASH) Group

36. A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy

40. First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013

43. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

48. Unmet needs in the scientific approach to older patients with lymphoma

49. Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium

Catalog

Books, media, physical & digital resources